See more : Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd (600721.SS) Income Statement Analysis – Financial Results
Complete financial analysis of Bite Acquisition Corp. (BITE-UN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Bite Acquisition Corp., a leading company in the Shell Companies industry within the Financial Services sector.
- Basilix Cert (BAS.BR) Income Statement Analysis – Financial Results
- Nature’s Miracle Holding Inc. Common Stock (NMHI) Income Statement Analysis – Financial Results
- Schindler Holding AG (SHLAF) Income Statement Analysis – Financial Results
- Mediclinic International plc (ANHGY) Income Statement Analysis – Financial Results
- Planet Labs PBC (PL-WT) Income Statement Analysis – Financial Results
Bite Acquisition Corp. (BITE-UN)
About Bite Acquisition Corp.
Bite Acquisition Corp. does not have significant business. It focuses on effecting a merger, share exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company intends to focus its search on the traditional and non-traditional restaurant sectors in North America. Bite Acquisition Corp. was incorporated in 2020 and is based in New York, New York.
| Metric | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 2.86M | 1.12M | 0.00 | 0.00 |
| Gross Profit | -2.86M | -1.12M | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 718.99K | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 2.86M | 1.12M | 718.99K | 802.00 |
| Other Expenses | -146.80K | 1.33M | 200.71K | 0.00 |
| Operating Expenses | 3.01M | 1.33M | 919.69K | 802.00 |
| Cost & Expenses | 3.01M | 1.33M | 919.69K | 802.00 |
| Interest Income | 1.04M | 0.00 | 11.36K | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 167.90K | -2.56M | -110.00K | 206.30K |
| EBITDA | -3.01M | -3.89M | -1.03M | -800.00 |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -3.01M | -1.33M | -919.69K | -800.00 |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 2.51M | 2.80M | 121.36K | -2.00 |
| Income Before Tax | -492.62K | 1.47M | -798.33K | -802.00 |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 495.32K | 477.78K | -11.36K | 0.00 |
| Net Income | -987.94K | 991.84K | -786.97K | -802.00 |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.11 | 0.04 | -0.03 | 0.00 |
| EPS Diluted | -0.11 | 0.04 | -0.03 | 0.00 |
| Weighted Avg Shares Out | 8.59M | 24.89M | 25.61M | 22.47M |
| Weighted Avg Shares Out (Dil) | 8.59M | 24.89M | 25.61M | 22.47M |
Source: https://incomestatements.info
Category: Stock Reports